A detailed history of Met Life Investment Management, LLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 70,240 shares of CTKB stock, worth $453,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70,240
Previous 70,240 -0.0%
Holding current value
$453,750
Previous $391,000 0.51%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.3 - $6.91 $38,467 - $50,152
7,258 Added 11.52%
70,240 $391,000
Q1 2024

May 14, 2024

BUY
$6.29 - $9.15 $396,156 - $576,285
62,982 New
62,982 $422,000
Q3 2023

May 09, 2024

BUY
$5.52 - $9.5 $10,769 - $18,534
1,951 Added 3.2%
62,982 $347,000
Q2 2023

Apr 29, 2024

BUY
$6.69 - $11.99 $421,349 - $755,154
62,982 New
62,982 $537,000
Q2 2023

Aug 10, 2023

BUY
$6.69 - $11.99 $13,052 - $23,392
1,951 Added 3.2%
62,982 $537,000
Q1 2023

May 09, 2024

BUY
$8.44 - $13.47 $515,101 - $822,087
61,031 New
61,031 $561 Million
Q2 2022

May 10, 2024

BUY
$7.41 - $11.56 $46,512 - $72,562
6,277 Added 11.46%
61,031 $654,000
Q2 2022

Mar 22, 2023

BUY
$7.41 - $11.56 $46,512 - $72,562
6,277 Added 11.46%
61,031 $654,000
Q2 2022

Aug 11, 2022

BUY
$7.41 - $11.56 $46,512 - $72,562
6,277 Added 11.46%
61,031 $655,000
Q1 2022

May 10, 2024

BUY
$9.89 - $17.25 $541,517 - $944,506
54,754 New
54,754 $590,000
Q1 2022

Jun 20, 2023

SELL
$9.89 - $17.25 $62,079 - $108,278
-6,277 Reduced 10.28%
54,754 $590,000
Q1 2022

Mar 22, 2023

BUY
$9.89 - $17.25 $477,736 - $833,261
48,305 Added 749.03%
54,754 $590,000
Q1 2022

May 12, 2022

BUY
$9.89 - $17.25 $477,736 - $833,261
48,305 Added 749.03%
54,754 $590,000
Q4 2021

Jun 21, 2023

SELL
$16.14 - $25.04 $880,953 - $1.37 Million
-54,582 Reduced 89.43%
6,449 $105,000
Q3 2021

May 17, 2024

SELL
$17.52 - $27.93 $990,458 - $1.58 Million
-56,533 Reduced 89.76%
6,449 $138,000
Q3 2021

Jun 21, 2023

SELL
$17.52 - $27.93 $956,276 - $1.52 Million
-54,582 Reduced 89.43%
6,449 $138,000
Q3 2021

Mar 22, 2023

SELL
$17.52 - $27.93 $956,276 - $1.52 Million
-54,582 Reduced 89.43%
6,449 $138,000
Q3 2021

Nov 15, 2021

BUY
$17.52 - $27.93 $112,986 - $180,120
6,449 New
6,449 $138,000

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $870M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.